SCL vs TMO · P/E 22, rev $2.18B vs P/E 24, rev $44.56B
Stepan Company (SCL) versus Thermo Fisher Scientific Inc (TMO) — a side-by-side from cached financials, not a winner call.
Stepan Company (SCL) is a specialty chemicals company listed on US.
Thermo Fisher Scientific Inc (TMO) is a diagnostics & research company listed on US.
Latest reported SCL revenue for 2024-12-31 was $2.18B. Net income was $50.4M. Revenue was down 6.3% from 2023-12-31 to 2024-12-31. SCL currently screens at market cap $1.29B and trailing P/E 22.3.
Latest reported TMO revenue for 2025-12-31 was $44.56B. Net income was $6.70B. Revenue was up 3.9% from 2024-12-31 to 2025-12-31. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
SCL currently screens at market cap $1.29B and trailing P/E 22.3. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
Not investment advice. Open the SCL and TMO stock pages for the full models.
Not investment advice.